Janni, Wolfgang
Janni, Wolfgang (1967- ).
Wolfgang Janni researcher
VIAF ID: 80282946 ( Personal )
Permalink: http://viaf.org/viaf/80282946
Preferred Forms
- 100 1 _ ‡a Janni, Wolfgang
-
-
- 100 1 _ ‡a Janni, Wolfgang
- 100 1 _ ‡a Janni, Wolfgang
-
- 100 0 _ ‡a Wolfgang Janni ‡c researcher
4xx's: Alternate Name Forms (2)
5xx's: Related Names (6)
- 510 2 _ ‡a Frauenklinik ‡g Düsseldorf ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Königliche Universitäts-Frauenklinik ‡g München ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Königliche Universitäts-Frauenklinik
- 551 _ _ ‡a München ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Tumorzentrum München
- 510 2 _ ‡a Universitäts-Frauenklinik Ulm ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts | |
Brustkrebs : Patientenratgeber zu den AGO-Empfehlungen 2018 | |
clinical relevance of the NATALEE study: application of the NATALEE criteria to a real-world cohort from two large German breast cancer centers | |
Erkrankungen der Vulva | |
Facharztwissen Gynäkologie | |
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study | |
Ginekologia, diagnostyka różnicowa i terapia : decyduj mądrze - lecz dobrze | |
Gynäkologie Differenzialdiagnostik und Differenzialtherapie : klug entscheiden - gut behandeln | |
Im Mittelpunkt Leben Wieder stark werden nach Brustkrebs | |
Klinikmanual Gynäkologie und Geburtshilfe | |
Mammakarzinome | |
Publizieren, Promovieren - leicht gemacht step by step | |
Ribociclib verlängertes Gesamtüberleben bei Patientinnen mit lokal fortgeschrittenem oder metastasiertem HR+/HER2- Mammakrzinom | |
Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer – controversies and standards in healthcare |